Ipsen Pharma Biotech manufactures pharmaceutical products. The company offers drugs to treat neurology, endocrinology, uro-oncology, hematology, gastroenterology, cardiovascular, and cognitive disorders. Ipsen Pharma Biotech serves patients worldwide.
In India, the Pharmaceutical business of Ipsen Pharma S.A.S. is focused on Growth Hormone Releasing Peptides.
Ipsen Pharma S.A.S. filed patent application numbered 7744/DELNP/2012 that is titled PHARMACEUTICAL COMPOSITIONS OF GROWTH HORMONE SECRETAGOGUE RECEPTOR LIGANDS. This patent application has been granted as Patent Number 316970.
The invention covers Pharmaceuticals compound. The present invention relates to improvements in compositions containing peptides that are ligands of the GHS receptor, or pharmaceutically acceptable salts thereof, methods for preparing such compositions, and methods of using such compositions to treat mammals. In particular, the present invention relates to a pharmaceutical composition comprising a pamoate salt of H-Inp-D-Bal-D-Trp-Phe-Apc-NH2, which is a ligand of the GHS receptor and in which, after subcutaneous or intramuscular administration to a subject, the peptide forms an in situ depot at physiological pH that is slowly dissolved and released into the body fluid and bloodstream. The present invention may further comprise an organic component such as dimethylacetamide (DMA) or polyethylene glycol with an average molecular weight of lower than 1000.
During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act that the subject matter of claims 1-7, 14, 19, 22, 24, 27, 28 and 29 of instant application relates to mere use of an already known substance and is objected U/S 3(d) of the Act. Peptide has already been disclosed in cited art.
As a response to said objection, the applicant submits that, In order to overcome this objection we have amended the claims to highlight the invention. The present invention claims novel pharmaceutical composition which is a clear solution, a gel or a semi-solid, or a suspension comprising a pamoate salt of peptide. And thereby the composition structure and difference was depicted.
Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.
Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).
Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.
